Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer

Clinical trial NCT00707304 · COMPLETED

Trial details

NCT number: NCT00707304
Sponsor: Agennix
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer

Start date: 2008-11-01
Primary completion: 2011-03-01
Enrollment: 742

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.